Literature DB >> 15297523

Use of positive blood cultures for direct identification and susceptibility testing with the vitek 2 system.

Marina de Cueto1, Esther Ceballos, Luis Martinez-Martinez, Evelio J Perea, Alvaro Pascual.   

Abstract

In order to further decrease the time lapse between initial inoculation of blood culture media and the reporting of results of identification and antimicrobial susceptibility tests for microorganisms causing bacteremia, we performed a prospective study in which specially processed fluid from positive blood culture bottles from Bactec 9240 (Becton Dickinson, Cockeysville, Md.) containing aerobic media were directly inoculated into Vitek 2 system cards (bio-Mérieux, France). Organism identification and susceptibility results were compared with those obtained from cards inoculated with a standardized bacterial suspension obtained following subculture to agar; 100 consecutive positive monomicrobic blood cultures, consisting of 50 gram-negative rods and 50 gram-positive cocci, were included in the study. For gram-negative organisms, 31 of the 50 (62%) showed complete agreement with the standard method for species identification, while none of the 50 gram-positive cocci were correctly identified by the direct method. For gram-negative rods, there were 50% categorical agreements between the direct and standard methods for all drugs tested. The very major error rate was 2.4%, and the major error rate was 0.6%. The overall error rate for gram-negatives was 6.6%. Complete agreement in clinical categories of all antimicrobial agents evaluated was obtained for 19 of 50 (38%) gram-positive cocci evaluated; the overall error rate was 8.4%, with 2.8% minor errors, 2.4% major errors, and 3.2% very major errors. These findings suggest that the Vitek 2 cards inoculated directly from positive Bactec 9240 bottles do not provide acceptable bacterial identification or susceptibility testing in comparison with corresponding cards tested by a standard method.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15297523      PMCID: PMC497633          DOI: 10.1128/JCM.42.8.3734-3738.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  Evaluation of a new system, VITEK 2, for identification and antimicrobial susceptibility testing of enterococci.

Authors:  F Garcia-Garrote; E Cercenado; E Bouza
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Direct bacterial identification from positive BacT/Alert blood cultures using MicroScan overnight and rapid panels.

Authors:  K B Waites; E S Brookings; S A Moser; B L Zimmer
Journal:  Diagn Microbiol Infect Dis       Date:  1998-09       Impact factor: 2.803

3.  Evaluation of the VITEK 2 system for rapid identification of medically relevant gram-negative rods.

Authors:  G Funke; D Monnet; C deBernardis; A von Graevenitz; J Freney
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

4.  Direct susceptibility testing with positive BacT/Alert blood cultures by using MicroScan overnight and rapid panels.

Authors:  K B Waites; E S Brookings; S A Moser; B L Zimmer
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

5.  Direct identification and susceptibility testing of enteric bacilli from positive blood cultures using VITEK (GNI+/GNS-GA).

Authors:  D S Hansen; A G Jensen; N Nørskov-Lauritsen; R Skov; B Bruun
Journal:  Clin Microbiol Infect       Date:  2002-01       Impact factor: 8.067

6.  Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing.

Authors:  J Barenfanger; C Drake; G Kacich
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

7.  The impact of same-day tests versus traditional overnight testing.

Authors:  P A Granato
Journal:  Diagn Microbiol Infect Dis       Date:  1993 Mar-Apr       Impact factor: 2.803

8.  Evaluation of the VITEK 2 system for the identification and susceptibility testing of three species of nonfermenting gram-negative rods frequently isolated from clinical samples.

Authors:  P Joyanes; M del Carmen Conejo; L Martínez-Martínez; E J Perea
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

9.  Rapid identification and antibiotic susceptibility testing of Salmonella enterica serovar Typhi isolated from blood: implications for therapy.

Authors:  S K Saha; G L Darmstadt; A H Baqui; M Hanif; M Ruhulamin; M Santosham; T Nagatake; R E Black
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

10.  Clinical impact of rapid in vitro susceptibility testing and bacterial identification.

Authors:  G V Doern; R Vautour; M Gaudet; B Levy
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

View more
  28 in total

1.  Rapid identification of bacteria from positive blood culture bottles by use of matrix-assisted laser desorption-ionization time of flight mass spectrometry fingerprinting.

Authors:  Martin Christner; Holger Rohde; Manuel Wolters; Ingo Sobottka; Karl Wegscheider; Martin Aepfelbacher
Journal:  J Clin Microbiol       Date:  2010-03-17       Impact factor: 5.948

2.  Evaluation of the Merlin MICRONAUT system for rapid direct susceptibility testing of gram-positive cocci and gram-negative bacilli from positive blood cultures.

Authors:  Nele Wellinghausen; Tim Pietzcker; Sven Poppert; Syron Belak; Nicole Fieser; Melanie Bartel; Andreas Essig
Journal:  J Clin Microbiol       Date:  2007-01-03       Impact factor: 5.948

3.  Use of PCR coupled with electrospray ionization mass spectrometry for rapid identification of bacterial and yeast bloodstream pathogens from blood culture bottles.

Authors:  Erin J Kaleta; Andrew E Clark; Desiree R Johnson; Dulini C Gamage; Vicki H Wysocki; Abdessalam Cherkaoui; Jacques Schrenzel; Donna M Wolk
Journal:  J Clin Microbiol       Date:  2010-11-03       Impact factor: 5.948

4.  Comparative evaluation of Vitek 2 identification and susceptibility testing of Gram-negative rods directly and isolated from BacT/ALERT-positive blood culture bottles.

Authors:  M J Munoz-Dávila; G Yagüe; M Albert; T García-Lucas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-28       Impact factor: 3.267

5.  Direct disk diffusion test using European Clinical Antimicrobial Susceptibility Testing breakpoints provides reliable results compared with the standard method.

Authors:  Sofia Stokkou; Gernot Geginat; Dirk Schlüter; Ina Tammer
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-03-26

6.  Blood Culture Turnaround Time in U.S. Acute Care Hospitals and Implications for Laboratory Process Optimization.

Authors:  Ying P Tabak; Latha Vankeepuram; Gang Ye; Kay Jeffers; Vikas Gupta; Patrick R Murray
Journal:  J Clin Microbiol       Date:  2018-11-27       Impact factor: 5.948

7.  Comparative evaluation of Vitek 2 identification and susceptibility testing of urinary tract pathogens directly and isolated from chromogenic media.

Authors:  M J Munoz-Dávila; M Roig; G Yagüe; A Blázquez; C Salvador; M Segovia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-01-12       Impact factor: 3.267

8.  Direct antimicrobial susceptibility testing from the blood culture pellet obtained for MALDI-TOF identification of Enterobacterales and Pseudomonas aeruginosa.

Authors:  J M López-Pintor; C Navarro-San Francisco; J Sánchez-López; A García-Caballero; E Loza Fernández de Bobadilla; M I Morosini; R Cantón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-02-02       Impact factor: 3.267

9.  Direct identification of bacteria in positive blood culture bottles by matrix-assisted laser desorption ionisation time-of-flight mass spectrometry.

Authors:  Bernard La Scola; Didier Raoult
Journal:  PLoS One       Date:  2009-11-25       Impact factor: 3.240

10.  Rapid identification and antimicrobial susceptibility profiling of Gram-positive cocci in blood cultures with the Vitek 2 system.

Authors:  A Lupetti; S Barnini; B Castagna; A-L Capria; P H Nibbering
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-10       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.